A Drug Utilization Study to Evaluate Indicators of Adherence to the Risk Minimization Measures for Ritlecitinib Using Electronic Healthcare Data in Denmark, France, and Sweden First published 21/05/2025 Last updated 21/05/2025 EU PAS number:EUPAS1000000523 Study Planned